Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
Renasant Bio has raised $54.5M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
Renasant Bio's investors include OrbiMed, 5AM Ventures, Atlas Venture, Qiming Venture Partners USA.
Renasant Bio is headquartered in Berkeley, United States.
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
Renasant Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Renasant Bio — Funding & Investors." VCBacked, July 10, 2025, https://www.vcbacked.co/company/renasant-bio. Accessed September 3, 2026.
VCBacked. (2025). Renasant Bio — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/renasant-bio
{{cite web |title=Renasant Bio — Funding & Investors |url=https://www.vcbacked.co/company/renasant-bio |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated